Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Benazepril and Hydrochlorothiazide · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg |
| 2 | ACTIVE_COMPARATOR | Lotensin HCT® Tablets 20 mg/25 mg |
| Name | Type | Description |
|---|---|---|
| Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg | DRUG | 20/25mg, single dose fed |
| Lotensin HCT® Tablets 20 mg/25 mg | DRUG | 20/25mg, single dose fed |
Inclusion Criteria: * 1\. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. 1. Women of childbearing potential must have negative serum -human chorionic gonadotropin (β-HCG) pregnancy tests performed within 14 days prior to the start of the study and on the evening...